Growth-plate state
Local control of the cellular and spatial programs that shape longitudinal skeletal growth.
Company in formation
Controlled growth-plate biology for regenerative orthopedics.
Aufrecht Therapeutics is forming around local control of growth-plate state, repair, and architecture.
Domain
growth-plate biology and regenerative orthopedics
Recruiting
scientific leadership, advisors, aligned seed investors
Private materials
technical memo available by request
01 / Thesis
Standing within limits.
Longitudinal skeletal growth depends on a precise architecture: a stem-cell niche, zonal patterning, columnar chondrocyte organization, controlled hypertrophic differentiation, regulated ossification boundaries, vascular timing, and mechanical integration with bone.
Aufrecht focuses on the local biological control required for durable repair: niche state, spatial organization, controlled differentiation, and integration with surrounding bone.
02 / Focus
Growth-plate state. Architecture. Translation.
Architecture
Preservation of zonal patterning, columnar order, boundaries, and integration with adjacent bone.
Translation
A disciplined path from early biology toward clinically credible regenerative orthopedics.
03 / Current Ask
Recruiting scientific leadership, advisors, and aligned seed investors.
-
Scientific lead
Growth-plate and skeletal stem-cell leadership
CSO-level expertise in skeletal biology, regenerative orthopedics, or growth-plate biology.
-
Advisors
Clinical and translational counsel
Pediatric orthopedics, local delivery, formulation, regulatory, and translational planning.
-
Capital
Aligned seed investors
Capital partners comfortable with decision-stage biology and disciplined early translational work.
-
Materials
Technical memo available privately
Detailed scientific rationale, budget, and translational plan available after introductory review.
04 / Formation
Focused on translation.
Aufrecht is being formed by Robert Malka and Dr. Ignacio Baselga-Carretero, with scientific advisory, clinical, and delivery expertise being assembled around the first program.
CEO
Robert Malka
Scientific formation
Ignacio Baselga-Carretero, PhD
Scientific advisory board
In formation
Recruiting
CSO, pediatric orthopedics, delivery, formulation
Qualified scientific and capital conversations.
For CSO, advisor, and investor inquiries, send a short note. Robert Malka will reply directly.